Ocuphire Pharma PE Ratio 2010-2024 | IRD
Current and historical p/e ratio for Ocuphire Pharma (IRD) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Ocuphire Pharma PE ratio as of October 24, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Ocuphire Pharma PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-10-24 | 1.13 | 0.00 | |
2024-06-30 | 1.53 | $-0.55 | 0.00 |
2024-03-31 | 2.01 | $-0.49 | 0.00 |
2023-12-31 | 3.01 | $-0.48 | 0.00 |
2023-09-30 | 3.35 | $1.31 | 2.56 |
2023-06-30 | 4.34 | $0.84 | 5.17 |
2023-03-31 | 3.75 | $0.83 | 4.52 |
2022-12-31 | 3.53 | $0.76 | 4.64 |
2022-09-30 | 2.01 | $-1.17 | 0.00 |
2022-06-30 | 1.92 | $-1.20 | 0.00 |
2022-03-31 | 3.24 | $-1.47 | 0.00 |
2021-12-31 | 3.73 | $-4.69 | 0.00 |
2021-09-30 | 5.15 | $-4.34 | 0.00 |
2021-06-30 | 5.28 | $-4.09 | 0.00 |
2021-03-31 | 5.81 | $-6.05 | 0.00 |
2020-12-31 | 6.49 | $-3.08 | 0.00 |
2020-09-30 | 8.32 | $-3.08 | 0.00 |
2020-06-30 | 11.36 | $-5.04 | 0.00 |
2020-03-31 | 7.20 | $-5.00 | 0.00 |
2019-12-31 | 7.64 | $-6.88 | 0.00 |
2019-09-30 | 8.20 | $-10.72 | 0.00 |
2019-06-30 | 20.64 | $-16.92 | 0.00 |
2019-03-31 | 24.48 | $-20.25 | 0.00 |
2018-12-31 | 44.64 | $-21.13 | 0.00 |
2018-09-30 | 85.44 | $-21.61 | 0.00 |
2018-06-30 | 67.68 | $-15.37 | 0.00 |
2018-03-31 | 72.48 | $-8.16 | 0.00 |
2017-12-31 | 96.96 | $-48.02 | 0.00 |
2017-09-30 | 116.16 | $-43.70 | 0.00 |
2017-06-30 | 137.28 | $-46.58 | 0.00 |
2017-03-31 | 244.80 | $-52.82 | 0.00 |
2016-12-31 | 68.11 | $-19.21 | 0.00 |
2016-09-30 | 100.80 | $-28.81 | 0.00 |
2016-06-30 | 120.58 | $-33.61 | 0.00 |
2016-03-31 | 158.45 | $-38.42 | 0.00 |
2015-12-31 | 174.24 | $-38.42 | 0.00 |
2015-09-30 | 249.60 | $-33.61 | 0.00 |
2015-06-30 | 291.70 | $-28.81 | 0.00 |
2015-03-31 | 350.40 | $-19.21 | 0.00 |
2014-12-31 | 336.00 | $-52.82 | 0.00 |
2014-09-30 | 388.80 | $-52.82 | 0.00 |
2014-06-30 | 417.60 | $-57.62 | 0.00 |
2014-03-31 | 518.40 | $-72.03 | 0.00 |
2013-12-31 | 244.80 | $-33.61 | 0.00 |
2013-09-30 | 218.35 | $-28.81 | 0.00 |
2013-06-30 | 213.12 | $-19.21 | 0.00 |
2013-03-31 | 146.40 | $-4.80 | 0.00 |
2012-12-31 | 148.80 | $-9.60 | 0.00 |
2012-09-30 | 242.40 | $-9.60 | 0.00 |
2012-06-30 | 153.60 | $-19.21 | 0.00 |
2012-03-31 | 254.40 | $-48.02 | 0.00 |
2011-12-31 | 180.48 | $-62.43 | 0.00 |
2011-09-30 | 480.00 | $-105.64 | 0.00 |
2011-06-30 | 595.20 | $-110.45 | 0.00 |
2011-03-31 | 566.40 | $-100.84 | 0.00 |
2010-12-31 | 537.60 | $-86.43 | 0.00 |
2010-09-30 | 556.80 | $-52.82 | 0.00 |
2010-06-30 | 686.40 | $-48.02 | 0.00 |
2010-03-31 | 777.60 | $-43.22 | 0.00 |
2009-12-31 | 326.40 | $-48.02 | 0.00 |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Fanhua (AIFU) | China | $0.086B | 2.07 |
Top KingWin (WAI) | China | $0.008B | 0.00 |
S&W Seed (SANW) | United States | $0.006B | 0.00 |
Invo BioScience (NAYA) | United States | $0.004B | 0.00 |